Synthesis and pharmacology of benzodiazepine derivatives
Synthesis and pharmacology of benzodiazepine derivatives is a research topic within Organic Chemistry. Science Explorer counts 5.8k research works in it since 1950. 7.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the chemistry, synthesis, and biological evaluation of pyrrolobenzodiazepines, a class of DNA-interactive agents with potent antitumour activity. The research covers topics such as asymmetric synthesis, cross-linking agents, cytotoxicity, and their application in natural product synthesis.
- Pyrrolobenzodiazepines
- Synthesis
- DNA-Interactive Agents
- Antitumour Activity
- Asymmetric Synthesis
- Isoindolinones
- Cross-Linking Agents
- Biological Evaluation
- Cytotoxicity
- Natural Products
- Research works
- 5.8k fractional, since 1950
- In the world top 10%
- 404 per year above
- Top-10% rate
- 7.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -44% the tick is no change
Which countries lead Synthesis and pharmacology of benzodiazepine derivatives research?
By volume, China and India publish the most (75 and 55 works in 2022–2025).
By volume, 2022–2025
- 1 China 75 works
- 2 India 55 works
- 3 United States 26 works
- 4 Russia 23 works
- 5 Japan 13 works
- 6 United Kingdom 10 works
- 7 Iran 9 works
- 8 Germany 8 works
- 9 France 6 works
- 10 Ukraine 6 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Synthesis and pharmacology of benzodiazepine derivatives research?
By volume in 2022–2025, Henan Normal University publishes the most Synthesis and pharmacology of benzodiazepine derivatives research, followed by Peoples' Friendship University of Russia and Academy of Scientific and Innovative Research.
By volume, 2022–2025
- 1 Henan Normal UniversityChina 3 works
- 2 Peoples' Friendship University of RussiaRussia 3 works
- 3 Academy of Scientific and Innovative ResearchIndia 2 works
- 4 Delhi Technological UniversityIndia 2 works
- 5 University of MadrasIndia 2 works
- 6 Indian Institute of Technology GuwahatiIndia 2 works
- 7 Novosibirsk Institute of Organic ChemistryRussia 2 works
- 8 Ruđer Bošković InstituteCroatia 2 works
- 9 The University of OsakaJapan 2 works
- 10 N.D. Zelinsky Institute of Organic ChemistryRussia 2 works
Who are the leading researchers in Synthesis and pharmacology of benzodiazepine derivatives?
The most-cited researchers publishing on Synthesis and pharmacology of benzodiazepine derivatives include Alan R. Katritzky and Paul Knochel.
- 1 Alan R. Katritzky United States 2.3k citations
- 2 Paul Knochel Germany 1.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Synthesis and pharmacology of benzodiazepine derivatives research done?
The largest centres of Synthesis and pharmacology of benzodiazepine derivatives research in 2022–2025 are Beijing (China), Moscow (Russia), Shanghai (China) and Tehran (Iran).
Is Synthesis and pharmacology of benzodiazepine derivatives research growing?
Output in 2018–2022 was 44% lower than in 2013–2017, peaking in 2013.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.